Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding developmental processes. While not exact replicas of human organs, they ...
Leveraging the power of AI and machine learning technologies, researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Researchers at the University of Michigan and University of Minnesota find women often lack sufficient information about general bladder health.
In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...
Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).
Reusable Incontinence Products Market The reusable incontinence products market is set to grow from USD 5.8 Bn in 2025 to USD 8.3 Bn by 203 ...
Center for Cancer Diagnosis and Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province 215000, China ...
Over the years, the Prancing Horse company created three models labeled GTO (Gran Turismo Omologato) – the 1962 to 1964 Ferrari 250 GTO, the 1984-87 Ferrari 288 GTO, and the 2011 Ferrari 599 GTO.
Bill sets fines of up to $38 million or 7% of turnover on companies Aligned with EU's AI Act, it targets transparency and bans harmful practices New AI supervisory agency AESIA to enforce most ...
However, little is known about the expression profile of the AFI axis in the bladder and its role in bladder function and dysfunction. We have examined the expression profile of 11 AFI family members ...
This prospective open-label, randomised study found using mpMRI in the muscle-invasive bladder cancer pathway reduced the time to correct treatment by 45 days compared to standard investigation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results